Showing results (321-330 of 413) with videos related to
Sort By:
Pageof 42
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2008
Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trialsBernhard C Pestalozzi, David Zahrieh, Elizabeth Mallon, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2007
CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trialsA Keshaviah, S Dellapasqua, N Rotmensz, et al.Journal of Economic Entomology|August 3, 2020
Geographic Distribution of Bacillus thuringiensis Cry1F Toxin Resistance in Western Bean Cutworm (Lepidoptera: Noctuidae) Populations in the United StatesBrad S Coates, Craig A Abel, Katharine A Swoboda-Bhattarai, et al.Breast Cancer Research and Treatment|February 4, 2014
Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequencesAndrea Decensi, Zhuoxin Sun, Aliana Guerrieri-Gonzaga, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2001
Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancerM Colleoni, S Gelber, A S Coates, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2019
Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFTOlivia Pagani, Prudence A Francis, Gini F Fleming, et al.Breast Cancer Research and Treatment|March 29, 2018
Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00Elisabetta Munzone, Kathryn P Gray, Caterina Fumagalli, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2016
Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: TEXT and SOFT TrialsMeredith M Regan, Prudence A Francis, Olivia Pagani, et al.Clinical Breast Cancer|July 25, 2008
A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37Irene L Wapnir, Stefan Aebi, Charles E Geyer, et al.Breast Cancer Research and Treatment|October 28, 2008
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93Olivia Pagani, Shari Gelber, Edda Simoncini, et al.Pageof 42